Histone demethylases KDM4C and KDM3C were recently identified as a signaling effector of mutated JAK2 and a target gene of the transcription factor NFE2, which is overexpressed in myeloproliferative neoplasms [84, 87, 88]. This evidence concerns the gene JAK2 and myeloproliferative disorder.